EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Incorporating Real Option Value in Valuing Innovation: A Way Forward

Meng Li iD, Louis P Garrison

PharmacoEconomics · 2024-07 · 42 (S2) · 199-210

DOI: 10.1007/s40273-024-01352-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PharmacoEconomics, online erschienen am 04.02.2024. Verfasst von Meng Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washingto…. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Models, Economic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Benefit AnalysisModels, EconomicHumansTechnology Assessment, BiomedicalUncertaintyBiomedical Technology

Autor:innen und Institutionen

  • Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, Boston, MA, 02111, USA. Meng.li@tuftsmedicalcenter.org.
  • The CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA.

ORCID-Profile: Meng Li

Zitieren

APA

Li, M., & Garrison, L. P. (2024). Incorporating Real Option Value in Valuing Innovation: A Way Forward. PharmacoEconomics, 42(S2), 199-210. https://doi.org/10.1007/s40273-024-01352-4

Vancouver

Li M, Garrison LP. Incorporating Real Option Value in Valuing Innovation: A Way Forward. PharmacoEconomics. 2024;42(S2):199-210. doi:10.1007/s40273-024-01352-4

BibTeX
@article{Li2024,
  author = {Li, Meng and Garrison, Louis P},
  title = {Incorporating Real Option Value in Valuing Innovation: A Way Forward},
  journal = {PharmacoEconomics},
  year = {2024},
  volume = {42},
  number = {S2},
  pages = {199--210},
  doi = {10.1007/s40273-024-01352-4}
}
Kostenlos starten →